Mintz has advised Axoft. Axoft, a neurotechnology company specializing in soft, implantable brain-computer interfaces (iBCIs), has secured $55 million in Series A funding. This investment is...
Axoft Raises $55 Million Series A to Advance Global Clinical Trials for Soft Brain-Computer Interfaces
Axoft’s $8 Million Seed Round Financing
Mintz represented Axoft on the deal. Axoft, a neurotechnology company, announced its $8 million seed round led by The Engine, a venture firm spun out of MIT...